Effect of Toxoplasma lysate antigen (TLA) on feline cytotoxicity against FeLV positive lymphoma cells.
The cytotoxic activities of feline spleen cells treated with Toxoplasma lysate antigen (TLA) were assayed against feline leukemia virus (FeLV)-producing lymphoma. FL74 cells, and xenogeneic target lymphoma, mouse YAC-1 cells. The TLA treatments were performed in vivo alone, in vitro alone, and in vivo plus in vitro, respectively. In vivo plus in vitro treatments with TLA induced a marked augmentation in cytotoxic activity of spleen cells to FL74 cells. The treatment with TLA in vivo alone showed an enhancement of cytotoxic activity but in vitro alone did not. The cytotoxic effects of TLA-treated spleen cells obtained from the cats which had been previously immunized with live FL74 cells were similar to those of spleen cells from non-immunized cats treated with TLA. However, no increase of cytotoxicity was shown in the response to mouse YAC-1 cells regardless of TLA treatments. These results indicated that the in vivo TLA treatment augmented the cytotoxicity of feline spleen cells against FeLV-producing lymphoma cell.
Yang
M P
MP
Department of Veterinary Internal Medicine, Faculty of Agriculture, University of Tokyo, Japan.
Goitsuka
R
R
Ono
K
K
Suzuki
N
N
Hasegawa
A
A
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology / Q000494:pharmacology*; D002371:Cat Diseases / Q000276:immunology*; D002415:Cats; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005256:Leukemia Virus, Feline / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology*; D013160:Splenic Neoplasms / Q000276:immunology / Q000662:veterinary*; D014122:Toxoplasma / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000276:immunology
D000953:Antigens, Protozoan